Kinnate biopharma stock price
WebKinnate Biopharma Inc. Compare NASDAQ Health Care Biotechnology Pre-market trading US stock markets open in 3 hours Regular trading $5.46 +0.79 updated 13 hours ago 16.92% Pre-market $5.66 +0.20 updated 13 hours ago 3.66% RSI 50.66 Compare with other stocks Intraday 16.92% 5 days 57.80% 1 month 20.98% 3 months 15.35% 6 … Web13 nov. 2024 · Kinnate Biopharma has an analyst consensus of Strong Buy, with a price target consensus of $34.20, a 257.74% upside from current levels. In a report released on November 11, Wedbush also...
Kinnate biopharma stock price
Did you know?
Web26 aug. 2024 · SAN DIEGO, Calif.-- ( BUSINESS WIRE )--Kinnate Biopharma Inc., a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically-defined cancers, today announced that it has raised $98 million in a Series C financing. Web3 dec. 2024 · SAN FRANCISCO and SAN DIEGO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) ... Kinnate Biopharma Announces Pricing of …
WebCash, cash equivalents and investments of $262.1 million as of September 30, 2024; cash runway expected to fund operations into mid-2024 SAN FRANCISCO and SAN DIEGO, … Web11 okt. 2024 · Therefore, the Zacks rating upgrade for Kinnate Biopharma Inc. basically reflects positivity about its earnings outlook that could translate into buying pressure and …
Web4 apr. 2024 · Stock quotes by finanzen.net; ... company name Date shares traded shares held Price type (sell/buy) option ... Kinnate Biopharma Inc. 12/06/2024 500,001
WebKNTE Stock 12 Months Forecast. $27.00. (342.62% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Kinnate Biopharma in the last 3 months. …
Web20 mrt. 2024 · Currently, the analyst consensus on Kinnate Biopharma is a Moderate Buy with an average price target of $22.00. See Insiders’ Hot Stocks on TipRanks >> Based on Kinnate Biopharma’s... play the song if i loved youWebThe forecasts range from a low of $8.08 to a high of $37.80. The average price target represents an increase of 360.40% from its latest reported closing price of $6.14. See … play the song i got no rootsWebBased on 5 Wall Street analysts offering 12 month price targets for Kinnate Biopharma in the last 3 months. The average price target is $27.00 with a high forecast of $36.00 and a low forecast of $8.00. The average price target represents a 342.62% change from the last price of $6.10. Highest Price Target $36.00 Average Price Target $27.00 play the song if you want me to stayWeb2 uur geleden · UXIN, TAST and ENVB among mid-day movers. Apr 14, 2024 17:00 UTC. S SAI C CXAI O OBLG A ALLR play the song i love youWeb17 mrt. 2024 · Mar 15, 2024. 10-K. Annual report which provides a comprehensive overview of the company for the past year. Annual Filings. 0001140361-23-011846.pdf. 0001140361-23-011846.rtf. 0001140361-23-011846.xls. EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML. primula iced tea maker instructionsWebKinnate BioPharma Inc. $ 6.11 +9.30 % ( 1W) $ Disclosure The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. primula lexington insulated french pressWebAnalyst Price Forecast Suggests 360.40% Upside As of April 6, 2024, the average one-year price target for Kinnate Biopharma is $28.27. The forecasts range from a low of $8.08 to a high of... play the song if i can dream by elvis presley